|
|
Volumn 10, Issue 1, 2006, Pages 77-81
|
|
Ovarian cancer screening: a look at the evidence.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CA 125 ANTIGEN;
COLONY STIMULATING FACTOR 1;
LYSOPHOSPHOLIPID;
TUMOR MARKER;
BLOOD;
CANCER STAGING;
CAUSE OF DEATH;
COCARCINOGENESIS;
EARLY DIAGNOSIS;
ECHOGRAPHY;
EVIDENCE BASED MEDICINE;
FEMALE;
GENETIC SCREENING;
HUMAN;
MASS SCREENING;
METABOLISM;
METHODOLOGY;
ORGANIZATION AND MANAGEMENT;
OVARY TUMOR;
PREVALENCE;
PROTEOMICS;
REVIEW;
RISK FACTOR;
SENSITIVITY AND SPECIFICITY;
STANDARD;
SURVIVAL RATE;
TUMOR SUPPRESSOR GENE;
UNITED STATES;
CA-125 ANTIGEN;
CAUSE OF DEATH;
COCARCINOGENESIS;
EARLY DIAGNOSIS;
EVIDENCE-BASED MEDICINE;
FEMALE;
GENES, BRCA1;
GENES, BRCA2;
GENETIC SCREENING;
HUMANS;
LYSOPHOSPHOLIPIDS;
MACROPHAGE COLONY-STIMULATING FACTOR;
MASS SCREENING;
NEOPLASM STAGING;
OVARIAN NEOPLASMS;
PREVALENCE;
PROTEOMICS;
RISK FACTORS;
SENSITIVITY AND SPECIFICITY;
SURVIVAL RATE;
TUMOR MARKERS, BIOLOGICAL;
ULTRASONOGRAPHY;
UNITED STATES;
|
|
EID: 33644973014
PISSN: 10921095
EISSN: None
Source Type: Journal
DOI: 10.1188/06.cjon.77-81 Document Type: Review |
|
Times cited : (39)
|
|
References (31)
|
